Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
novoMOF is a Swiss materials science company specializing in the development and large-scale production of Metal-Organic Frameworks (MOFs). These highly porous crystalline materials are engineered for specific molecular interactions, enabling applications in carbon capture, gas separation, and water harvesting. In the life sciences sector, novoMOF leverages its platform to develop advanced solutions for targeted drug delivery and medical imaging contrast agents. The company focuses on bridging the gap between laboratory-scale MOF synthesis and industrial-grade manufacturing. Their proprietary technology allows for the customization of MOF structures to encapsulate various therapeutic cargos or imaging labels. By providing high-quality, scalable MOF materials, novoMOF supports partners in the pharmaceutical and diagnostic industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on novoMOF.